Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
15.10. | IQ-AI Limited - IQ-AI Issues Letter to Shareholders | - | RNS | ||
14.10. | IQ-AI Limited - PDMR dealing and TR1 announcement | - | RNS | ||
14.10. | IN BRIEF: Braveheart buys 30% stake in IQ-AI from Braveheart CEO Brown | 1 | Alliance News | ||
11.10. | IQ-AI Limited - Acquisition of Interest by Braveheart | 1 | RNS | ||
11.10. | Braveheart Inv Group - Investment in IQ-AI Limited and RPT | - | RNS | ||
13.08. | IQ-AI Limited - Half-year Report | - | RNS | ||
25.06. | IN BRIEF: IQ-AI subsidiary opens expanded access programme | 1 | Alliance News | ||
25.06. | IQ-AI Limited - IB Opens Expanded Access Program | - | RNS | ||
14.06. | IQ-AI team begins defining phase 2 protocol for oral gallium maltolate | 1 | Alliance News | ||
14.06. | IQ-AI Limited - Clinical Trial Updates | - | RNS | ||
29.05. | IQ-AI Limited - Result of AGM | 1 | RNS | ||
23.05. | IQ-AI Limited - Major East Coast Health System Chooses IB Nimble | - | RNS | ||
20.05. | IQ-AI subsidiary gets second FDA rare paediatric disease designation | 2 | Alliance News | ||
20.05. | IQ-AI Limited - Second FDA Rare Pediatric Disease Designation | - | RNS | ||
17.05. | IQ-AI Limited - IB Software Enhances Clinical Decision-Making | 1 | RNS | ||
10.05. | IQ-AI subsidiary gets rare paediatric disease designation FDA | 1 | Alliance News | ||
10.05. | IQ-AI Limited - Rare Pediatric Disease Designation Granted to GaM | - | RNS |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
GERRESHEIMER | 78,60 | +1,42 % | Aurubis, BMW, Gerresheimer, SGL Carbon, ThyssenKrupp, Zalando u.a. - Aktien-Positionen der Shortseller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
MCKESSON | 487,30 | +0,27 % | McKesson Aktie: Ausgezeichnete Quartalszahlen! | ||
LIMES SCHLOSSKLINIKEN | 356,00 | 0,00 % | EQS-Adhoc: Limes Schlosskliniken AG: Positiver Geschäftsverlauf I. Halbjahr 2024 | EQS-Ad-hoc: Limes Schlosskliniken AG / Schlagwort(e): Halbjahresbericht/Vorläufiges Ergebnis
Limes Schlosskliniken AG: Positiver Geschäftsverlauf I. Halbjahr 2024
18.07.2024 / 10:17 CET/CEST
Veröffentlichung... ► Artikel lesen | |
BEYOND AIR | 0,490 | +8,41 % | Beyond Air Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update | Appointed industry veteran, David Webster, as new Chief Commercial Officer Recently upgraded LungFit PH device expands customer base; revenue growth expected to accelerateeach quarter going forward... ► Artikel lesen | |
CLEARDAY | - | - | Clearday, Inc.: Tech Centric Healthcare Services Company Continues To Move Forward With Its Business Combination and Exchange Listing | San Antonio, Texas, July 22, 2024 (GLOBE NEWSWIRE) -- Clearday (CLRD:OTC EXMKT) ("Clearday" or the "Company") is pleased to inform market participants, partners and stakeholders of the Company's efforts... ► Artikel lesen | |
INTERPACE BIOSCIENCES | 2,060 | -4,63 % | Interpace Biosciences, Inc.: Interpace Biosciences Announces Capital Restructuring of Its Preferred Stock as a First Step Toward Seeking an Uplisting of Its Common Stock to Nasdaq | PARSIPPANY, NJ, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. ("Interpace" or the "Company") (OTCQX: IDXG) today announced that its Series B Preferred Stock investors, Ampersand Capital... ► Artikel lesen | |
HEALTHCARE SERVICES GROUP | 10,200 | -0,97 % | HCSG Reports Q3 2024 Results | BENSALEM, Pa.--(BUSINESS WIRE)--Healthcare Services Group, Inc. (NASDAQ:HCSG) today reported results for the three months ended September 30, 2024.
Ted Wahl, Chief Executive Officer, stated, "We're... ► Artikel lesen | |
ADDUS HOMECARE | 112,00 | 0,00 % | Addus HomeCare Announces Second Quarter 2024 Financial Results | FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the second quarter and six months ended June... ► Artikel lesen | |
ICU MEDICAL | 156,00 | -1,89 % | Smiths Group Sells 1.2 Mln Shares In ICU Medical | LONDON (dpa-AFX) - Smiths Group Plc (SMIN.L), an engineering firm, confirmed on Wednesday that it has sold 1.2 million shares in ICU Medical Inc. or around 4.9 percent of ICU's share capital.... ► Artikel lesen | |
MODERN DENTAL | 0,432 | -3,14 % | EQS Newswire: Modern Dental Group Limited: Modern Dental Group Shared the Technological Innovation in Dentistry Along the Development of New Quality Productive Forces in CCB International Forum | EQS Newswire / 30/09/2024 / 15:43 UTC+8
Modern Dental Group Shared the Technological Innovation in Dentistry Along the Development of New Quality Productive Forces in CCB International Forum
... ► Artikel lesen | |
XYLO TECHNOLOGIES | 3,400 | -0,87 % | XYLO TECHNOLOGIES LTD - 6-K, Report of foreign issuer | ||
ACADIA HEALTHCARE | 39,000 | -4,41 % | Acadia Healthcare Reports Strong Third Quarter 2024 Results | FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the third quarter and nine months ended September 30, 2024.
Third Quarter... ► Artikel lesen | |
FRESH2 GROUP | 1,910 | +15,76 % | Fresh2 Group Ltd. Announces Receipt of an Additional Delinquency Compliance Alert Notice from Nasdaq | New York, NY, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Fresh2 Group Ltd. (NASDAQ: FRES) ("Fresh2" or the "Company"), a B2B e-commerce and supply chain management company within the restaurant and food industry... ► Artikel lesen | |
MEDIPAL | 14,100 | -2,08 % | Dividendenbekanntmachungen (27.09.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN EUROPEAN LOGISTICS INCOME PLC GB00BD9PXH49 0,0077 GBP EUR ACADIAN TIMBER CORP CA0042721005 0,29 CAD 0,1926 EUR ACOM CO LTD JP3108600002 7... ► Artikel lesen | |
THERACLION | 0,361 | +2,85 % | Theraclion Announces Major Advances and Reports First-Half Financial Results | On the strength of its progress on its 2023 and 2024 priorities (access to the US market, R&D and China), Theraclion is planning its commercial ramp-up for 2025 and 2026. Pivotal study for... ► Artikel lesen |